Guidant Corp.

Recent Events

News & Analysis

guidant corp. and performance - All News and Analysis

• Guidant Initiates Suit for Specific Performance; Company Reports Third Quarter Sales of $795 Million

  - 2005-11-07

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT), a world leader in the treatment of cardiac and vascular disease, announced that it is initiating a lawsuit today in the United States District Court for the Southern District of New York against Johnson & Johnson seeking specific performance of Johnson & Johnson's obligation to...

  Tags: Guidant Corp., performance

• Guidant Announces Completion of FDA Inspection of St. Paul Facilities and Responds to FDA's Observations; Company Continues to Work with Stakeholders to Establish Industry Standards for Communicating Device Performance

  - 2005-09-22

  INDIANAPOLIS -- Guidant (NYSE:GDT) announced today that the U.S. Food and Drug Administration FDA has completed its inspection of Guidant's Cardiac Rhythm Management facilities in St. Paul, Minnesota, and has provided Guidant a Form 483, noting several observations of non-compliance, including an observation with commentary on two specific trends in...

  Tags: FDA, Guidant Corp., industry standard, performance

• Lawsuit dismissal generates Wall Street yawns: Guidant legal troubles unlikely to affect performance.

  - 2004-11-22

  A federal judge recently dismissed one claim against Guidant Corp. over its failed venture with Endovascular Technologies Inc., but much legal wrangling remains on that ill-fated front. A federal judge recently dismissed one claim against Guidant Corp. over its failed venture with Endovascular Technologies...

  Tags: Guidant Corp., performance

• Guidant Submits Application for FDA Approval of MULTI-LINK VISION Cobalt Chromium Coronary Stent; Stent System Incorporates Innovative Material for Excellent Performance

  - 2002-10-24

  Business Editors/Health and Medical Writers

  Tags: FDA, Guidant Corp., performance

• Guidant Reports Record Third Quarter Sales of $662 million; Double Digit Growth From Balanced Geographic Performance Earnings Per Share Reach $0.40

  - 2001-10-18

  Business & Health/Medical Editors

  Tags: Guidant Corp., performance

• First Patients Treated with Guidant's Next Generation Coronary Stent; Latest Stent Constructed of New Material Designed to Enhance Performance

  - 2001-08-15

  Business Editors & Health/Medical Writers

  Tags: Guidant Corp., performance

• Guidant Clarifies Performance Issue With Limited Subset of Pacemakers

  - 1999-03-31

  INDIANAPOLIS--BW HealthWire--March 31, 1999--Guidant Corporation (NYSE:GDT) (PCX:GDT), today announced it is conducting an action in the field to notify physicians of the potential for early battery depletion in a limited number of its DISCOVERYTM, MERIDIANTM, and PULSARTM pacemaker devices. No deaths or serious injuries have been observed due to this...

  Tags: Guidant Corp., performance